Invasive candidiasis

@article{Pappas2018InvasiveC,
  title={Invasive candidiasis},
  author={P. Pappas and M. Lionakis and M. Arendrup and L. Ostrosky-Zeichner and B. Kullberg},
  journal={Nature Reviews Disease Primers},
  year={2018},
  volume={4}
}
Invasive candidiasis is an important health-care-associated fungal infection that can be caused by several Candida spp.; the most common species is Candida albicans, but the prevalence of these organisms varies considerably depending on geographical location. The spectrum of disease of invasive candidiasis ranges from minimally symptomatic candidaemia to fulminant sepsis with an associated mortality exceeding 70%. Candida spp. are common commensal organisms in the skin and gut microbiota, and… Expand

Paper Mentions

An Investigation into Clinically Relevant Determinants of Azole Resistance in Candida albicans
TLDR
A novel finding correcting a previous mistaken paradigm of a clinically relevant mechanism driving resistance in C. albicans is found, where the contribution of MRR2 mutations to azole resistance through changes in CDR1 expression and fluconazole minimum inhibitory concentrations (MICs) is measured. Expand
Invasive candidiasis in critical care: challenges and future directions
TLDR
The shift in Candida epidemiology across the globe to more resistant non-albicans species, in particular, the emergence of multi-resistant Candida glabrata and Candida auris pose significant treatment and infection control challenges in critical care. Expand
The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives
TLDR
It is argued that a detailed understanding of these variables, which underlie fungal-host-microbiota interactions, will present opportunities for directed antifungal therapies that benefit vulnerable patients. Expand
Update on Candida krusei, a potential multidrug-resistant pathogen.
TLDR
The current knowledge of the biology, pathophysiology and epidemiology of a potential multidrug-resistant fungal pathogen, C. krusei, is reviewed, while also discussing the mechanisms of drug resistance of Candida species and alternative therapeutic approaches. Expand
Diagnosis of Invasive Candidiasis: From Gold Standard Methods to Promising Leading-edge Technologies.
TLDR
The currently available methods for invasive Candidiasis diagnosis are reviewed and their strengths, utility, limitations as well as combined use to assist in the diagnosis of this life-threatening and costly fungal infection are discussed. Expand
Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation
TLDR
This model allowed analysis of the virulence traits of Candida strains in individual mice including colonization in the gut, penetration into intestinal mucosa, invasion into blood vessels, and the subsequent dissemination leading to lethal infections. Expand
Vancomycin enhances growth and virulence of Trichosporon spp. planktonic cells and biofilms.
TLDR
Results suggest that antibiotic exposure may have a direct impact on the pathophysiology of opportunistic trichosporonosis in patients at risk and the stimulatory effect of vancomycin on fungal cells should be considered in a clinical scenario. Expand
The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine.
TLDR
The commensal lifestyle of C. albicans in the intestine, the role of morphology for Commensalism, the influence of diet, and the interactions with bacteria of the microbiota are discussed. Expand
COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
TLDR
Despite the marked immune dysregulation in COVID-19, no prominent defects have been reported in immune cells that are critically required for immunity to Candida, which suggests that relevant clinical factors, including prolonged ICU stays, central venous catheters, and broad-spectrum antibiotic use, may be key factors causing COVIDs patients to develop IYIs. Expand
Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans
TLDR
The identification of FLC tolerance mediators in C. albicans was addressed by an overexpression strategy focusing on 572 C.Albicans genes, suggesting the involvement of multiple mechanisms. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 390 REFERENCES
Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally
TLDR
Alarmingly, in a span of only 7 years, this yeast, which is difficult to treat and displays clonal interand intra-hospital transmission, has become widespread across several countries, causing a broad range of healthcare-associated invasive infections. Expand
Candida and Host Determinants of Susceptibility to Invasive Candidiasis
TLDR
A mouse model of the infection, which introduces Candida yeast cells intravenously and mimics skin-derived bloodstream human candidiasis, has been successfully employed to study fungal and host factors that regulate susceptibility to the infection. Expand
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
TLDR
In patients with C. albicans infection, anidulafungin was more effective than fluconazole, with more rapid clearance of positive blood cultures, which suggests that the fungicidal activity of echinocandins may have important clinical implications. Expand
Invasive Candidiasis.
TLDR
Invasive candidiasis is the most common fungal disease among hospitalized patients in the developed world, and the global shift in favor of nonalbicans candida species is troubling, as is the emerging resistance to antifungal drugs. Expand
Impact of yeast-bacteria coinfection on the detection of Candida sp. in an automated blood culture system.
TLDR
Results showed that, in a standard microorganism medium, bacterial growth could hide the fungal development, and in patients at risk of invasive candidiasis, the use of a specific fungal medium could improve the diagnosis and allow an earlier efficient antifungal treatment. Expand
Epidemiology of invasive candidiasis
  • M. Arendrup
  • Medicine
  • Current opinion in critical care
  • 2010
TLDR
The changing epidemiology highlights the need for close monitoring of local incidence, species distribution and susceptibility in order to optimize therapy and outcome and host factors are dominating predictors of mortality in recent studies of ICU candidiasis. Expand
Candida albicans pathogenicity mechanisms
TLDR
This review presents an update on the current understanding of the pathogenicity mechanisms of this important human pathogen and reveals novel virulence mechanisms have recently been discovered. Expand
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.
  • M. Cuenca‐Estrella, P. Verweij, +22 authors A. Ullmann
  • Medicine
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2012
As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and toExpand
New insights into innate immune control of systemic candidiasis
TLDR
In this review, the new developments in understanding of how the mammalian immune system responds to systemic Candida challenge are synthesized and important future research directions are highlighted. Expand
The risk and clinical outcome of candidemia depending on underlying malignancy
TLDR
Analysis of the episodes of fungemia due to common Candida species in adults in adults based on an active hospital-based surveillance program found the clinical context of underlying malignancy and hospitalization in ICU may be relevant to the initial management of candidemia. Expand
...
1
2
3
4
5
...